{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:29:41Z","timestamp":1790116181366,"version":"4.0.1"},"reference-count":80,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiovascular diseases are one of the leading causes of mortality and morbidity worldwide. The pathogenesis of this group of disorders is highly complex and involves interactions between various cell types and substances, among others, catestatin (CTS). In recent years, numerous researchers have expanded our knowledge about CTS\u2019s role in development and its potential for the treatment of a variety of diseases. In this review, the authors discuss CTS\u2019s importance in the pathogenesis of arterial hypertension, coronary artery disease, and heart failure. Moreover, we present CTS\u2019s influence on heart and vessel function.<\/jats:p>","DOI":"10.3390\/ijms26062417","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:22:52Z","timestamp":1741350172000},"page":"2417","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Catestatin in Cardiovascular Diseases"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7057-6282","authenticated-orcid":false,"given":"Joanna","family":"Kulpa","sequence":"first","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Paduch","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0475-6187","authenticated-orcid":false,"given":"Marcin","family":"Szczepanik","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9288-8689","authenticated-orcid":false,"given":"Anna","family":"Gor\u0105cy-Rosik","sequence":"additional","affiliation":[{"name":"Independent Laboratory of Invasive Cardiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7377-4566","authenticated-orcid":false,"given":"Jakub","family":"Rosik","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Tch\u00f3rz","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-1208","authenticated-orcid":false,"given":"Andrzej","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Gor\u0105cy","sequence":"additional","affiliation":[{"name":"Independent Laboratory of Invasive Cardiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41569-021-00607-3","article-title":"Epidemiology of cardiovascular disease in Europe","volume":"19","author":"Townsend","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Watanabe, T. (2021). The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116118"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/mgr.MEDGASRES-D-23-00013","article-title":"Oxygen-ozone therapy for myocardial ischemic stroke and cardiovascular disorders","volume":"15","author":"Pandolfi","year":"2025","journal-title":"Med. Gas Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gor\u0105cy, J., Gor\u0105cy, A., W\u00f3jcik-Grzeszczuk, A., Gor\u0105cy, I., and Rosik, J. (2022). Analysis of Genetic Variants in the Glucocorticoid Receptor Gene. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081912"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tan, S.C.W., Zheng, B.B., Tang, M.L., Chu, H., Zhao, Y.T., and Weng, C. (2025). Global Burden of Cardiovascular Diseases and its Risk Factors, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021. QJM, hcaf022.","DOI":"10.1093\/qjmed\/hcaf022"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00726-023-03252-x","article-title":"Chromogranin A-derived peptides pancreastatin and catestatin: Emerging therapeutic target for diabetes","volume":"55","author":"Garg","year":"2023","journal-title":"Amino Acids"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zalewska, E., Kmie\u0107, P., and Sworczak, K. (2022). Role of Catestatin in the Cardiovascular System and Metabolic Disorders. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.909480"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bozic, J., Kumric, M., Ticinovic Kurir, T., Urlic, H., Martinovic, D., Vilovic, M., Tomasovic Mrcela, N., and Borovac, J.A. (2021). Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121757"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1158\/1078-0432.CCR-24-1875","article-title":"Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study","volume":"30","author":"Meng","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Vanli Tonyali, N., Karabay, G., Arslan, B., Aktemur, G., Tokgoz Cakir, B., Seyhanli, Z., Demir \u00c7endek, B., Yilmaz Ergani, S., Eroglu, H., and Mermi, S. (2025). Maternal Serum Catestatin Levels in Gestational Diabetes Mellitus: A Potential Biomarker for Risk Assessment and Diagnosis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14020435"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wo\u0142owiec, \u0141., Banach, J., Budzy\u0144ski, J., Wo\u0142owiec, A., Kozakiewicz, M., Bieli\u0144ski, M., Ja\u015bniak, A., Olejarczyk, A., and Grze\u015bk, G. (2023). Prognostic Value of Plasma Catestatin Concentration in Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134208"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12031-012-9728-2","article-title":"Chromogranin A and derived peptides in health and disease","volume":"48","author":"Loh","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2021.11.002","article-title":"Putative regulation of macrophage-mediated inflammation by catestatin","volume":"43","author":"Muntjewerff","year":"2022","journal-title":"Trends Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bourebaba, Y., Mularczyk, M., Marycz, K., and Bourebaba, L. (2021). Catestatin peptide of chromogranin A as a potential new target for several risk factors management in the course of metabolic syndrome. Biomed. Pharmacother., 134.","DOI":"10.1016\/j.biopha.2020.111113"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41371-020-00477-1","article-title":"Hypertension trials update","volume":"35","author":"Kulenthiran","year":"2021","journal-title":"J. Hum. Hypertens."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvn155","article-title":"Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure","volume":"80","author":"Mahapatra","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/en.2008-0318","article-title":"The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine\/paracrine modulator of cardiac inotropism and lusitropism","volume":"149","author":"Angelone","year":"2008","journal-title":"Endocrinology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/HYPERTENSIONAHA.120.16809","article-title":"Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin)","volume":"77","author":"Ying","year":"2021","journal-title":"Hypertension"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/hrt.75.4.330","article-title":"Cardioprotection: Definition, classification, and fundamental principles","volume":"75","author":"Haass","year":"1996","journal-title":"Heart"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1016\/j.jacc.2016.07.123","article-title":"GW27-e0952 Effect Of Catecholamine Release-Inhibitory Peptide Catestatin on Sympathetic Activity Of Hypertension","volume":"68","author":"Jianqiang","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-0115(03)00069-7","article-title":"Catestatin (CgA344\u2013364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides","volume":"114","author":"Mahata","year":"2003","journal-title":"Regul. Pept."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11010-019-03661-1","article-title":"Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling","volume":"464","author":"Alam","year":"2020","journal-title":"Mol. Cell Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/en.2009-1110","article-title":"Chromogranin a and the autonomic system: Decomposition of heart rate variability and rescue by its catestatin fragment","volume":"151","author":"Dev","year":"2010","journal-title":"Endocrinology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e029470","DOI":"10.1161\/JAHA.123.029470","article-title":"Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation","volume":"12","author":"Qiu","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e035415","DOI":"10.1161\/JAHA.124.035415","article-title":"Electrophysiological Mechanism of Catestatin Antiarrhythmia: Enhancement of","volume":"13","author":"Zhang","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"171077","DOI":"10.1016\/j.peptides.2023.171077","article-title":"The angiogenic neuropeptide catestatin exerts beneficial effects on human coronary vascular cells and cardiomyocytes","volume":"168","author":"Lener","year":"2023","journal-title":"Peptides"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bralewska, M., Pietrucha, T., and Sakowicz, A. (2023). Reduction in CgA-Derived CST Protein Level in HTR-8\/SVneo and BeWo Trophoblastic Cell Lines Caused by the Preeclamptic Environment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087124"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/JLB.3CRA1220-790RR","article-title":"The anti-inflammatory peptide Catestatin blocks chemotaxis","volume":"112","author":"Muntjewerff","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"170200","DOI":"10.1016\/j.peptides.2019.170200","article-title":"Catestatin in defense of oxidative-stress-induced apoptosis: A novel mechanism by activating the beta2 adrenergic receptor and PKB\/Akt pathway in ischemic-reperfused myocardium","volume":"123","author":"Chu","year":"2020","journal-title":"Peptides"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2018.12.025","article-title":"Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role","volume":"281","author":"Chen","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chen, H., Liu, D., Ge, L., Wang, T., Ma, Z., Han, Y., Duan, Y., Xu, X., Liu, W., and Yuan, J. (2019). Catestatin prevents endothelial inflammation and promotes thrombus resolution in acute pulmonary embolism in mice. Biosci. Rep., 39.","DOI":"10.1042\/BSR20192236"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"R1538","DOI":"10.1152\/ajpregu.00335.2010","article-title":"Catestatin in rat RVLM is sympathoexcitatory, increases barosensitivity, and attenuates chemosensitivity and the somatosympathetic reflex","volume":"299","author":"Gaede","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"R365","DOI":"10.1152\/ajpregu.00409.2011","article-title":"Catestatin, a chromogranin A-derived peptide, is sympathoinhibitory and attenuates sympathetic barosensitivity and the chemoreflex in rat CVLM","volume":"302","author":"Gaede","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2014.04.001","article-title":"Antihypertensive and neuroprotective effects of catestatin in spontaneously hypertensive rats: Interaction with GABAergic transmission in amygdala and brainstem","volume":"270","author":"Avolio","year":"2014","journal-title":"Neuroscience"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/00004872-200207000-00020","article-title":"Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension","volume":"20","author":"Kailasam","year":"2002","journal-title":"J. Hypertens."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.5152\/akd.2014.5536","article-title":"The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol","volume":"15","author":"Ayaz","year":"2015","journal-title":"Anatol. J. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2459\/JCM.0b013e328346c142","article-title":"Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension","volume":"12","author":"Meng","year":"2011","journal-title":"J. Cardiovasc. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/CIRCULATIONAHA.107.709105","article-title":"Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: Implications for secretion and blood pressure","volume":"118","author":"Zhu","year":"2008","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1507\/endocrj.EJ14-0471","article-title":"A common genetic variant of the chromogranin A-derived peptide catestatin is associated with atherogenesis and hypertension in a Japanese population","volume":"62","author":"Choi","year":"2015","journal-title":"Endocr. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.106.628859","article-title":"Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): Naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension","volume":"115","author":"Rao","year":"2007","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5847\/wjem.j.1920-8642.2022.055","article-title":"Prognostic differences of catestatin among young and elderly patients with acute myocardial infarction","volume":"13","author":"Xu","year":"2022","journal-title":"World J. Emerg. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000448987","article-title":"Plasma Catestatin in Patients with Acute Coronary Syndrome","volume":"136","author":"Xu","year":"2017","journal-title":"Cardiology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/14017431.2013.794951","article-title":"Plasma levels and potential roles of catestatin in patients with coronary heart disease","volume":"47","author":"Liu","year":"2013","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ehf2.15107","article-title":"Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction","volume":"12","author":"Chu","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/ehf2.12882","article-title":"Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: A report from the CATSTAT-HF study","volume":"7","author":"Borovac","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zhu, D., Xie, H., Wang, X., Liang, Y., Yu, H., and Gao, W. (2017). Catestatin-A Novel Predictor of Left Ventricular Remodeling After Acute Myocardial Infarction. Sci. Rep., 7.","DOI":"10.1038\/srep44168"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Palmrich, P., Schirwani-Hartl, N., Haberl, C., Haslinger, P., Heinzl, F., Zeisler, H., and Binder, J. (2023). Catestatin-A Potential New Therapeutic Target for Women with Preeclampsia? An Analysis of Maternal Serum Catestatin Levels in Preeclamptic Pregnancies. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185931"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/01443615.2021.1873922","article-title":"Serum catestatin level is increased in women with preeclampsia","volume":"42","author":"Hamzaoglu","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bralewska, M., Biesiada, L., Grzesiak, M., Rybak-Krzyszkowska, M., Huras, H., Gach, A., Pietrucha, T., and Sakowicz, A. (2021). Chromogranin A demonstrates higher expression in preeclamptic placentas than in normal pregnancy. BMC Pregnancy Childbirth, 21.","DOI":"10.1186\/s12884-021-04139-z"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4274\/tjod.galenos.2021.34946","article-title":"The role of maternal serum catestatin in the evaluation of preeclampsia and fetal cardiac functions","volume":"18","author":"Yaman","year":"2021","journal-title":"Turk. J. Obstet. Gynecol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Luketin, M., Mizdrak, M., Boric-Skaro, D., Martinovic, D., Tokic, D., Vilovic, M., Supe-Domic, D., Ticinovic Kurir, T., and Bozic, J. (2021). Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis. Biomolecules, 11.","DOI":"10.3390\/biom11030456"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.5114\/amsad.2020.95562","article-title":"Plasma catestatin level predicts sPESI score and mortality in acute pulmonary embolism","volume":"5","author":"Izci","year":"2020","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"P\u00e0mies, A., Llop, D., Ibarretxe, D., Rosales, R., Girona, J., Masana, L., Vallv\u00e9, J.C., and Paredes, S. (2024). Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis Patients. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25189910"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e160721189770","DOI":"10.2174\/1573403X16999201231203854","article-title":"Analysis of Heart Rate Variability and Implication of Different Factors on Heart Rate Variability","volume":"17","author":"Tiwari","year":"2021","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Borovac, J.A., Glavas, D., Susilovic Grabovac, Z., Supe Domic, D., D\u2019Amario, D., and Bozic, J. (2019). Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study. J. Clin. Med., 8.","DOI":"10.3390\/jcm8081132"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12265-014-9563-7","article-title":"Cardiac Electrical Activity in a Genomically \u201cHumanized\u201d Chromogranin A Monogenic Mouse Model with Hyperadrenergic Hypertension","volume":"7","author":"Dev","year":"2014","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/HYPERTENSIONAHA.116.06568","article-title":"Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway","volume":"68","author":"Kiranmayi","year":"2016","journal-title":"Hypertension"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"43840","DOI":"10.1074\/jbc.M112.407916","article-title":"Functional genetic variants of the catecholamine-release-inhibitory peptide catestatin in an Indian population: Allele-specific effects on metabolic traits","volume":"287","author":"Sahu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cvr\/cvr129","article-title":"A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium","volume":"91","author":"Bassino","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","article-title":"Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review","volume":"11","author":"Ralapanawa","year":"2021","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"29240","DOI":"10.3402\/fnr.v59.29240","article-title":"LDL biochemical modifications: A link between atherosclerosis and aging","volume":"59","author":"Alique","year":"2015","journal-title":"Food Nutr. Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Jebari-Benslaiman, S., Galicia-Garc\u00eda, U., Larrea-Sebal, A., Olaetxea, J.R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., and Mart\u00edn, C. (2022). Pathophysiology of Atherosclerosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063346"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Theofilis, P., Sagris, M., Oikonomou, E., Antonopoulos, A.S., Siasos, G., Tsioufis, C., and Tousoulis, D. (2021). Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070781"},{"key":"ref_64","first-page":"25","article-title":"LDL cholesterol and atherosclerosis: The evidence","volume":"33","author":"Guijarro","year":"2021","journal-title":"Clin. Investig. Arterioscler."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Muntjewerff, E.M., Dunkel, G., Nicolasen, M.J.T., Mahata, S.K., and van den Bogaart, G. (2018). Catestatin as a Target for Treatment of Inflammatory Diseases. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02199"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Xu, W., Yu, H., Li, W., Gao, W., Guo, L., and Wang, G. (2016). Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149062"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"134","DOI":"10.15420\/aer.2017.24.1","article-title":"Ventricular Arrhythmia after Acute Myocardial Infarction: \u2019The Perfect Storm\u2019","volume":"6","author":"Davies","year":"2017","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.peptides.2014.02.016","article-title":"Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction","volume":"55","author":"Pei","year":"2014","journal-title":"Peptides"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart Disease and Stroke Statistics: A Report of US and Global Data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2174\/0929867324666170425100416","article-title":"Catestatin: A Master Regulator of Cardiovascular Functions","volume":"25","author":"Mahata","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_72","first-page":"47","article-title":"Neurohumoral, cardiac and inflammatory markers in the evaluation of heart failure severity and progression","volume":"18","author":"Polyakova","year":"2021","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10571-010-9598-5","article-title":"Catestatin improves post-ischemic left ventricular function and decreases ischemia\/reperfusion injury in heart","volume":"30","author":"Penna","year":"2010","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"170904","DOI":"10.1016\/j.peptides.2022.170904","article-title":"Chronic catestatin treatment reduces atrial fibrillation susceptibility via improving calcium handling in post-infarction heart failure rats","volume":"159","author":"Yan","year":"2023","journal-title":"Peptides"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Bralewska, M., Pietrucha, T., and Sakowicz, A. (2024). The Role of Catestatin in Preeclampsia. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052461"},{"key":"ref_77","first-page":"48","article-title":"Pulmonary embolism: The Pulmonary Embolism Severity Index (PESI) score and mortality predictors","volume":"45","author":"Hassine","year":"2023","journal-title":"Pan Afr. Med. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-0042-1756204","article-title":"Pathophysiology and Management of Pulmonary Embolism","volume":"31","author":"Shah","year":"2022","journal-title":"Int. J. Angiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/ndt\/gfy174","article-title":"Cardiovascular disease in dialysis patients","volume":"33","author":"Cozzolino","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: A review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/6\/2417\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:10Z","timestamp":1760028550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/6\/2417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ijms26062417"],"URL":"https:\/\/doi.org\/10.3390\/ijms26062417","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}